This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Incyte Corp (INCY)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 511.50M 354.95M 297.06M 94.45M
Cost of Sales 3.00M 630.00K 157.00K 0.00
Gross Operating Profit 508.49M 354.32M 296.90M 94.45M
Selling, General, and Administrative Expenses 165.77M 109.98M 85.36M 58.22M
Research & Development 347.52M 260.44M 210.39M 178.71M
Operating Income before D & A (EBITDA) -4.80M -16.10M 1.15M -142.47M
Depreciation & Amortization 41.41M 29.21M 29.98M 26.99M
Interest Income 0.00 0.00 764.00K 462.00K
Other Income - Net 3.08M -28.09M 0.00 -712.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -43.13M -73.40M -28.07M -169.71M
Interest Expense 46.83M 38.65M 46.06M 43.82M
Pre-Tax Income -89.96M -112.06M -74.12M -213.53M
Income Taxes -66.00K 299.00K 174.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -48.48M -83.15M -44.32M -186.54M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -48.48M -83.15M -44.32M -186.54M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -48.48M -83.15M -44.32M -186.54M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-48.48M -83.15M -44.32M -186.54M
Preferred Dividends
Net Income Available To Common -48.48M -83.15M -44.32M -186.54M
Basic EPS from Continuing Ops. -0.29 -0.56 -0.34 -1.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.29 -0.56 -0.34 -1.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.29 -0.56 -0.34 -1.49
Basic Normalized Net Income/Share -0.29 -0.56 -0.34 -1.49
EPS fr Continuing Ops. -0.29 -0.56 -0.34 -1.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.29 -0.56 -0.34 -1.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.29 -0.56 -0.34 -1.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.29 -0.56 -0.34 -1.49
Dividends Paid per Share 0.00 0.00 0.00 0.00
INCY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for INCY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 11 11
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INCY ANALYST REPORT

INCY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs